Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on


Innovations in treatment options for abdominal aortic aneurysms

On this edition of Access Health, Ereka Vetrini is getting a closer look at abdominal aortic aneurysms, a condition known as the “silent killer.”

Abdominal aortic aneurysms are an extremely dangerous condition in which surgery is likely the next and only step for patients. Unfortunately, only 34% of women are eligible for endovascular aneurysm repair as compared to 54% of men due to anatomical differences.

Historically, women have not done well in surgery as there were no surgical options for smaller anatomies. However, the introduction of the Ovation Abdominal Stent Graft System has increased the eligibility of women by 28%.

Stay tuned as Ereka speaks with doctors and experts about the Ovation Abdominal Stent Graft System. Plus, learn more about the symptoms, risk factors, and life-saving treatment innovations helping to increase patients’ survival rates.


INDICATIONS FOR USE: The Ovation® iX Abdominal Stent Graft System is indicated for treatment of patients with abdominal aortic aneurysms having the vascular morphology suitable for endovascular repair, including: adequate iliac/femoral access compatible with vascular access techniques (femoral cutdown or percutaneous), devices, and/or accessories; proximal aortic landing zone: with an inner wall diameter of no less than 16 mm and no greater than 30 mm at 13 mm below the inferior renal artery, and with an aortic angle of ≤ 60 degrees if proximal neck is ≥ 10 mm and ≤ 45 degrees if proximal neck is < 10 mm; distal iliac landing zone: with a length of at least 10 mm, and with an inner wall diameter of no less than 8 mm and no greater than 25 mm.

CONTRAINDICATIONS: The system is contraindicated for use in patients who have a condition that threatens to infect the graft and in patients with known sensitivities or allergies to the device materials (including polytetrafluoroethylene [PTFE], polyethylene glycol [PEG]-based polymers, and fluorinated ethylene propylene [FEP] or nitinol).

Rx only.

Note: Endologix products and associated components are not available in all countries or regions. Please consult with your Endologix representative for details regarding product availability.

CE marked. Please refer to current product instructions for use.

Endologix is a registered trademark of Endologix, Inc. in United States, Europe and Japan and Ovation is a registered trademark of Endologix, Inc. and its subsidiaries in United States, Brazil, Canada, China, Europe, India, Mexico, and Japan. All other trademarks are the property of their respective owners.

©2019 Endologix, Inc. All rights reserved.




The Latest Innovations in Health & Nutrition

Stay tuned for the latest innovations in health and nutrition.


Innovations in Breast Cancer Radiation Therapy

Olga Villaverde is joined by Dr. Maria-Amelia Rodrigues, a Radiation Oncologist with Miami Cancer Institute, for a closer look at an innovative breast cancer radiation therapy.


The Importance of Fatty Acids in Parenteral Nutrition

We are joined by Dr. Sivan Kinberg, Director of the Pediatric Intestinal Rehabilitation Center at Columbia University in New York, to learn about the importance of fatty acids and calories in parenteral nutrition.